nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—OPRD1—coronary artery disease	0.64	1	CbGaD
Remifentanil—Sufentanil—OPRD1—coronary artery disease	0.00188	0.553	CrCbGaD
Remifentanil—Fentanyl—OPRD1—coronary artery disease	0.00064	0.188	CrCbGaD
Remifentanil—Alfentanil—ALB—coronary artery disease	0.000388	0.114	CrCbGaD
Remifentanil—Pethidine—CYP2C19—coronary artery disease	0.000315	0.0927	CrCbGaD
Remifentanil—Pethidine—ALB—coronary artery disease	0.000175	0.0514	CrCbGaD
Remifentanil—Dizziness—Ezetimibe—coronary artery disease	0.000111	0.000451	CcSEcCtD
Remifentanil—Body temperature increased—Enalapril—coronary artery disease	0.000111	0.000449	CcSEcCtD
Remifentanil—Feeling abnormal—Captopril—coronary artery disease	0.000111	0.000449	CcSEcCtD
Remifentanil—Rash—Fenofibrate—coronary artery disease	0.00011	0.000449	CcSEcCtD
Remifentanil—Dermatitis—Fenofibrate—coronary artery disease	0.00011	0.000448	CcSEcCtD
Remifentanil—Loss of consciousness—Timolol—coronary artery disease	0.00011	0.000448	CcSEcCtD
Remifentanil—Headache—Fenofibrate—coronary artery disease	0.00011	0.000446	CcSEcCtD
Remifentanil—Paraesthesia—Losartan—coronary artery disease	0.00011	0.000446	CcSEcCtD
Remifentanil—Urticaria—Telmisartan—coronary artery disease	0.00011	0.000445	CcSEcCtD
Remifentanil—Cough—Timolol—coronary artery disease	0.000109	0.000445	CcSEcCtD
Remifentanil—Vomiting—Clopidogrel—coronary artery disease	0.000109	0.000445	CcSEcCtD
Remifentanil—Diarrhoea—Simvastatin—coronary artery disease	0.000109	0.000445	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000109	0.000444	CcSEcCtD
Remifentanil—Tremor—Lisinopril—coronary artery disease	0.000109	0.000443	CcSEcCtD
Remifentanil—Body temperature increased—Telmisartan—coronary artery disease	0.000109	0.000443	CcSEcCtD
Remifentanil—Dyspnoea—Losartan—coronary artery disease	0.000109	0.000442	CcSEcCtD
Remifentanil—Anxiety—Ramipril—coronary artery disease	0.000109	0.000442	CcSEcCtD
Remifentanil—Vomiting—Lovastatin—coronary artery disease	0.000109	0.000442	CcSEcCtD
Remifentanil—Somnolence—Losartan—coronary artery disease	0.000109	0.000441	CcSEcCtD
Remifentanil—Dizziness—Eplerenone—coronary artery disease	0.000109	0.000441	CcSEcCtD
Remifentanil—Rash—Clopidogrel—coronary artery disease	0.000109	0.000441	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000109	0.000441	CcSEcCtD
Remifentanil—Dermatitis—Clopidogrel—coronary artery disease	0.000108	0.000441	CcSEcCtD
Remifentanil—Hypertension—Timolol—coronary artery disease	0.000108	0.00044	CcSEcCtD
Remifentanil—Pain—Furosemide—coronary artery disease	0.000108	0.00044	CcSEcCtD
Remifentanil—Constipation—Furosemide—coronary artery disease	0.000108	0.00044	CcSEcCtD
Remifentanil—Hypersensitivity—Niacin—coronary artery disease	0.000108	0.00044	CcSEcCtD
Remifentanil—Headache—Clopidogrel—coronary artery disease	0.000108	0.000438	CcSEcCtD
Remifentanil—Rash—Lovastatin—coronary artery disease	0.000108	0.000438	CcSEcCtD
Remifentanil—Dermatitis—Lovastatin—coronary artery disease	0.000108	0.000438	CcSEcCtD
Remifentanil—Anaemia—Lisinopril—coronary artery disease	0.000108	0.000437	CcSEcCtD
Remifentanil—Dyspepsia—Losartan—coronary artery disease	0.000108	0.000437	CcSEcCtD
Remifentanil—Feeling abnormal—Perindopril—coronary artery disease	0.000107	0.000436	CcSEcCtD
Remifentanil—Headache—Lovastatin—coronary artery disease	0.000107	0.000435	CcSEcCtD
Remifentanil—Pruritus—Valsartan—coronary artery disease	0.000107	0.000434	CcSEcCtD
Remifentanil—Dry mouth—Ramipril—coronary artery disease	0.000107	0.000434	CcSEcCtD
Remifentanil—Vomiting—Ezetimibe—coronary artery disease	0.000107	0.000433	CcSEcCtD
Remifentanil—Hypersensitivity—Pravastatin—coronary artery disease	0.000107	0.000433	CcSEcCtD
Remifentanil—Anxiety—Timolol—coronary artery disease	0.000106	0.000432	CcSEcCtD
Remifentanil—Pruritus—Olmesartan—coronary artery disease	0.000106	0.000432	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000106	0.000431	CcSEcCtD
Remifentanil—Body temperature increased—Captopril—coronary artery disease	0.000106	0.000431	CcSEcCtD
Remifentanil—Dizziness—Simvastatin—coronary artery disease	0.000106	0.00043	CcSEcCtD
Remifentanil—Rash—Ezetimibe—coronary artery disease	0.000106	0.00043	CcSEcCtD
Remifentanil—Dermatitis—Ezetimibe—coronary artery disease	0.000106	0.000429	CcSEcCtD
Remifentanil—Confusional state—Ramipril—coronary artery disease	0.000106	0.000429	CcSEcCtD
Remifentanil—Headache—Ezetimibe—coronary artery disease	0.000105	0.000427	CcSEcCtD
Remifentanil—Anaphylactic shock—Ramipril—coronary artery disease	0.000105	0.000426	CcSEcCtD
Remifentanil—Oedema—Ramipril—coronary artery disease	0.000105	0.000426	CcSEcCtD
Remifentanil—Dry mouth—Timolol—coronary artery disease	0.000104	0.000424	CcSEcCtD
Remifentanil—Constipation—Losartan—coronary artery disease	0.000104	0.000424	CcSEcCtD
Remifentanil—Pain—Losartan—coronary artery disease	0.000104	0.000424	CcSEcCtD
Remifentanil—Syncope—Lisinopril—coronary artery disease	0.000104	0.000424	CcSEcCtD
Remifentanil—Vomiting—Eplerenone—coronary artery disease	0.000104	0.000424	CcSEcCtD
Remifentanil—Feeling abnormal—Furosemide—coronary artery disease	0.000104	0.000424	CcSEcCtD
Remifentanil—Nausea—Fenofibrate—coronary artery disease	0.000104	0.000423	CcSEcCtD
Remifentanil—Pruritus—Niacin—coronary artery disease	0.000104	0.000422	CcSEcCtD
Remifentanil—Rash—Eplerenone—coronary artery disease	0.000104	0.00042	CcSEcCtD
Remifentanil—Urticaria—Perindopril—coronary artery disease	0.000103	0.00042	CcSEcCtD
Remifentanil—Hypersensitivity—Trandolapril—coronary artery disease	0.000103	0.00042	CcSEcCtD
Remifentanil—Dermatitis—Eplerenone—coronary artery disease	0.000103	0.00042	CcSEcCtD
Remifentanil—Diarrhoea—Valsartan—coronary artery disease	0.000103	0.00042	CcSEcCtD
Remifentanil—Confusional state—Timolol—coronary artery disease	0.000103	0.000419	CcSEcCtD
Remifentanil—Shock—Ramipril—coronary artery disease	0.000103	0.000419	CcSEcCtD
Remifentanil—Hypersensitivity—Enalapril—coronary artery disease	0.000103	0.000419	CcSEcCtD
Remifentanil—Body temperature increased—Perindopril—coronary artery disease	0.000103	0.000418	CcSEcCtD
Remifentanil—Diarrhoea—Olmesartan—coronary artery disease	0.000103	0.000418	CcSEcCtD
Remifentanil—Headache—Eplerenone—coronary artery disease	0.000103	0.000418	CcSEcCtD
Remifentanil—Nervous system disorder—Ramipril—coronary artery disease	0.000103	0.000417	CcSEcCtD
Remifentanil—Thrombocytopenia—Ramipril—coronary artery disease	0.000103	0.000417	CcSEcCtD
Remifentanil—Anaphylactic shock—Timolol—coronary artery disease	0.000102	0.000416	CcSEcCtD
Remifentanil—Oedema—Timolol—coronary artery disease	0.000102	0.000416	CcSEcCtD
Remifentanil—Pruritus—Pravastatin—coronary artery disease	0.000102	0.000416	CcSEcCtD
Remifentanil—Loss of consciousness—Lisinopril—coronary artery disease	0.000102	0.000416	CcSEcCtD
Remifentanil—Nausea—Clopidogrel—coronary artery disease	0.000102	0.000415	CcSEcCtD
Remifentanil—Tachycardia—Ramipril—coronary artery disease	0.000102	0.000415	CcSEcCtD
Remifentanil—Skin disorder—Ramipril—coronary artery disease	0.000102	0.000413	CcSEcCtD
Remifentanil—Vomiting—Simvastatin—coronary artery disease	0.000102	0.000413	CcSEcCtD
Remifentanil—Hypersensitivity—Telmisartan—coronary artery disease	0.000102	0.000413	CcSEcCtD
Remifentanil—Cough—Lisinopril—coronary artery disease	0.000102	0.000413	CcSEcCtD
Remifentanil—Nausea—Lovastatin—coronary artery disease	0.000102	0.000413	CcSEcCtD
Remifentanil—Hyperhidrosis—Ramipril—coronary artery disease	0.000101	0.000411	CcSEcCtD
Remifentanil—Rash—Simvastatin—coronary artery disease	0.000101	0.00041	CcSEcCtD
Remifentanil—Dermatitis—Simvastatin—coronary artery disease	0.000101	0.000409	CcSEcCtD
Remifentanil—Shock—Timolol—coronary artery disease	0.000101	0.000409	CcSEcCtD
Remifentanil—Feeling abnormal—Losartan—coronary artery disease	0.000101	0.000409	CcSEcCtD
Remifentanil—Urticaria—Furosemide—coronary artery disease	0.000101	0.000409	CcSEcCtD
Remifentanil—Diarrhoea—Niacin—coronary artery disease	0.0001	0.000408	CcSEcCtD
Remifentanil—Nervous system disorder—Timolol—coronary artery disease	0.0001	0.000408	CcSEcCtD
Remifentanil—Headache—Simvastatin—coronary artery disease	0.0001	0.000407	CcSEcCtD
Remifentanil—Body temperature increased—Furosemide—coronary artery disease	0.0001	0.000407	CcSEcCtD
Remifentanil—Dizziness—Valsartan—coronary artery disease	9.99e-05	0.000406	CcSEcCtD
Remifentanil—Nausea—Ezetimibe—coronary artery disease	9.96e-05	0.000405	CcSEcCtD
Remifentanil—Skin disorder—Timolol—coronary artery disease	9.95e-05	0.000404	CcSEcCtD
Remifentanil—Dizziness—Olmesartan—coronary artery disease	9.94e-05	0.000404	CcSEcCtD
Remifentanil—Pruritus—Trandolapril—coronary artery disease	9.94e-05	0.000404	CcSEcCtD
Remifentanil—Hyperhidrosis—Timolol—coronary artery disease	9.9e-05	0.000402	CcSEcCtD
Remifentanil—Pruritus—Enalapril—coronary artery disease	9.9e-05	0.000402	CcSEcCtD
Remifentanil—Diarrhoea—Pravastatin—coronary artery disease	9.89e-05	0.000402	CcSEcCtD
Remifentanil—Anxiety—Lisinopril—coronary artery disease	9.88e-05	0.000401	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.84e-05	0.0004	CcSEcCtD
Remifentanil—Hypotension—Ramipril—coronary artery disease	9.79e-05	0.000398	CcSEcCtD
Remifentanil—Pruritus—Telmisartan—coronary artery disease	9.76e-05	0.000396	CcSEcCtD
Remifentanil—Nausea—Eplerenone—coronary artery disease	9.75e-05	0.000396	CcSEcCtD
Remifentanil—Dizziness—Niacin—coronary artery disease	9.71e-05	0.000395	CcSEcCtD
Remifentanil—Urticaria—Losartan—coronary artery disease	9.7e-05	0.000394	CcSEcCtD
Remifentanil—Dry mouth—Lisinopril—coronary artery disease	9.69e-05	0.000394	CcSEcCtD
Remifentanil—Body temperature increased—Losartan—coronary artery disease	9.66e-05	0.000392	CcSEcCtD
Remifentanil—Diarrhoea—Trandolapril—coronary artery disease	9.61e-05	0.00039	CcSEcCtD
Remifentanil—Vomiting—Valsartan—coronary artery disease	9.6e-05	0.00039	CcSEcCtD
Remifentanil—Confusional state—Lisinopril—coronary artery disease	9.58e-05	0.000389	CcSEcCtD
Remifentanil—Diarrhoea—Enalapril—coronary artery disease	9.57e-05	0.000389	CcSEcCtD
Remifentanil—Hypotension—Timolol—coronary artery disease	9.57e-05	0.000389	CcSEcCtD
Remifentanil—Dizziness—Pravastatin—coronary artery disease	9.56e-05	0.000388	CcSEcCtD
Remifentanil—Vomiting—Olmesartan—coronary artery disease	9.56e-05	0.000388	CcSEcCtD
Remifentanil—Rash—Valsartan—coronary artery disease	9.52e-05	0.000387	CcSEcCtD
Remifentanil—Dermatitis—Valsartan—coronary artery disease	9.52e-05	0.000387	CcSEcCtD
Remifentanil—Nausea—Simvastatin—coronary artery disease	9.5e-05	0.000386	CcSEcCtD
Remifentanil—Oedema—Lisinopril—coronary artery disease	9.5e-05	0.000386	CcSEcCtD
Remifentanil—Anaphylactic shock—Lisinopril—coronary artery disease	9.5e-05	0.000386	CcSEcCtD
Remifentanil—Pruritus—Captopril—coronary artery disease	9.49e-05	0.000386	CcSEcCtD
Remifentanil—Rash—Olmesartan—coronary artery disease	9.48e-05	0.000385	CcSEcCtD
Remifentanil—Dermatitis—Olmesartan—coronary artery disease	9.47e-05	0.000385	CcSEcCtD
Remifentanil—Headache—Valsartan—coronary artery disease	9.46e-05	0.000384	CcSEcCtD
Remifentanil—Diarrhoea—Telmisartan—coronary artery disease	9.44e-05	0.000383	CcSEcCtD
Remifentanil—Headache—Olmesartan—coronary artery disease	9.42e-05	0.000383	CcSEcCtD
Remifentanil—Paraesthesia—Ramipril—coronary artery disease	9.41e-05	0.000382	CcSEcCtD
Remifentanil—Shock—Lisinopril—coronary artery disease	9.35e-05	0.00038	CcSEcCtD
Remifentanil—Dyspnoea—Ramipril—coronary artery disease	9.34e-05	0.000379	CcSEcCtD
Remifentanil—Vomiting—Niacin—coronary artery disease	9.34e-05	0.000379	CcSEcCtD
Remifentanil—Hypersensitivity—Furosemide—coronary artery disease	9.33e-05	0.000379	CcSEcCtD
Remifentanil—Somnolence—Ramipril—coronary artery disease	9.31e-05	0.000378	CcSEcCtD
Remifentanil—Thrombocytopenia—Lisinopril—coronary artery disease	9.3e-05	0.000378	CcSEcCtD
Remifentanil—Dizziness—Trandolapril—coronary artery disease	9.29e-05	0.000377	CcSEcCtD
Remifentanil—Tachycardia—Lisinopril—coronary artery disease	9.27e-05	0.000377	CcSEcCtD
Remifentanil—Rash—Niacin—coronary artery disease	9.26e-05	0.000376	CcSEcCtD
Remifentanil—Dermatitis—Niacin—coronary artery disease	9.25e-05	0.000376	CcSEcCtD
Remifentanil—Dizziness—Enalapril—coronary artery disease	9.25e-05	0.000376	CcSEcCtD
Remifentanil—Skin disorder—Lisinopril—coronary artery disease	9.23e-05	0.000375	CcSEcCtD
Remifentanil—Dyspepsia—Ramipril—coronary artery disease	9.22e-05	0.000375	CcSEcCtD
Remifentanil—Pruritus—Perindopril—coronary artery disease	9.21e-05	0.000374	CcSEcCtD
Remifentanil—Headache—Niacin—coronary artery disease	9.2e-05	0.000374	CcSEcCtD
Remifentanil—Paraesthesia—Timolol—coronary artery disease	9.2e-05	0.000374	CcSEcCtD
Remifentanil—Vomiting—Pravastatin—coronary artery disease	9.19e-05	0.000374	CcSEcCtD
Remifentanil—Hyperhidrosis—Lisinopril—coronary artery disease	9.18e-05	0.000373	CcSEcCtD
Remifentanil—Diarrhoea—Captopril—coronary artery disease	9.18e-05	0.000373	CcSEcCtD
Remifentanil—Dyspnoea—Timolol—coronary artery disease	9.13e-05	0.000371	CcSEcCtD
Remifentanil—Dizziness—Telmisartan—coronary artery disease	9.12e-05	0.000371	CcSEcCtD
Remifentanil—Rash—Pravastatin—coronary artery disease	9.12e-05	0.00037	CcSEcCtD
Remifentanil—Dermatitis—Pravastatin—coronary artery disease	9.11e-05	0.00037	CcSEcCtD
Remifentanil—Somnolence—Timolol—coronary artery disease	9.1e-05	0.00037	CcSEcCtD
Remifentanil—Headache—Pravastatin—coronary artery disease	9.06e-05	0.000368	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Ramipril—coronary artery disease	9.04e-05	0.000367	CcSEcCtD
Remifentanil—Dyspepsia—Timolol—coronary artery disease	9.01e-05	0.000366	CcSEcCtD
Remifentanil—Hypersensitivity—Losartan—coronary artery disease	9e-05	0.000366	CcSEcCtD
Remifentanil—Nausea—Valsartan—coronary artery disease	8.97e-05	0.000364	CcSEcCtD
Remifentanil—Pruritus—Furosemide—coronary artery disease	8.96e-05	0.000364	CcSEcCtD
Remifentanil—Constipation—Ramipril—coronary artery disease	8.96e-05	0.000364	CcSEcCtD
Remifentanil—Nausea—Olmesartan—coronary artery disease	8.93e-05	0.000363	CcSEcCtD
Remifentanil—Vomiting—Trandolapril—coronary artery disease	8.93e-05	0.000363	CcSEcCtD
Remifentanil—Diarrhoea—Perindopril—coronary artery disease	8.91e-05	0.000362	CcSEcCtD
Remifentanil—Vomiting—Enalapril—coronary artery disease	8.89e-05	0.000361	CcSEcCtD
Remifentanil—Hypotension—Lisinopril—coronary artery disease	8.88e-05	0.000361	CcSEcCtD
Remifentanil—Dizziness—Captopril—coronary artery disease	8.87e-05	0.00036	CcSEcCtD
Remifentanil—Rash—Trandolapril—coronary artery disease	8.85e-05	0.00036	CcSEcCtD
Remifentanil—Dermatitis—Trandolapril—coronary artery disease	8.85e-05	0.000359	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Timolol—coronary artery disease	8.84e-05	0.000359	CcSEcCtD
Remifentanil—Rash—Enalapril—coronary artery disease	8.82e-05	0.000358	CcSEcCtD
Remifentanil—Dermatitis—Enalapril—coronary artery disease	8.81e-05	0.000358	CcSEcCtD
Remifentanil—Headache—Trandolapril—coronary artery disease	8.8e-05	0.000357	CcSEcCtD
Remifentanil—Vomiting—Telmisartan—coronary artery disease	8.77e-05	0.000356	CcSEcCtD
Remifentanil—Headache—Enalapril—coronary artery disease	8.76e-05	0.000356	CcSEcCtD
Remifentanil—Pain—Timolol—coronary artery disease	8.76e-05	0.000356	CcSEcCtD
Remifentanil—Nausea—Niacin—coronary artery disease	8.72e-05	0.000354	CcSEcCtD
Remifentanil—Rash—Telmisartan—coronary artery disease	8.7e-05	0.000353	CcSEcCtD
Remifentanil—Dermatitis—Telmisartan—coronary artery disease	8.69e-05	0.000353	CcSEcCtD
Remifentanil—Diarrhoea—Furosemide—coronary artery disease	8.66e-05	0.000352	CcSEcCtD
Remifentanil—Pruritus—Losartan—coronary artery disease	8.64e-05	0.000351	CcSEcCtD
Remifentanil—Headache—Telmisartan—coronary artery disease	8.64e-05	0.000351	CcSEcCtD
Remifentanil—Feeling abnormal—Ramipril—coronary artery disease	8.63e-05	0.000351	CcSEcCtD
Remifentanil—Dizziness—Perindopril—coronary artery disease	8.61e-05	0.00035	CcSEcCtD
Remifentanil—Nausea—Pravastatin—coronary artery disease	8.59e-05	0.000349	CcSEcCtD
Remifentanil—Paraesthesia—Lisinopril—coronary artery disease	8.53e-05	0.000347	CcSEcCtD
Remifentanil—Vomiting—Captopril—coronary artery disease	8.53e-05	0.000346	CcSEcCtD
Remifentanil—Dyspnoea—Lisinopril—coronary artery disease	8.47e-05	0.000344	CcSEcCtD
Remifentanil—Rash—Captopril—coronary artery disease	8.46e-05	0.000344	CcSEcCtD
Remifentanil—Dermatitis—Captopril—coronary artery disease	8.45e-05	0.000343	CcSEcCtD
Remifentanil—Somnolence—Lisinopril—coronary artery disease	8.45e-05	0.000343	CcSEcCtD
Remifentanil—Feeling abnormal—Timolol—coronary artery disease	8.44e-05	0.000343	CcSEcCtD
Remifentanil—Headache—Captopril—coronary artery disease	8.4e-05	0.000341	CcSEcCtD
Remifentanil—Dizziness—Furosemide—coronary artery disease	8.37e-05	0.00034	CcSEcCtD
Remifentanil—Dyspepsia—Lisinopril—coronary artery disease	8.36e-05	0.00034	CcSEcCtD
Remifentanil—Diarrhoea—Losartan—coronary artery disease	8.36e-05	0.00034	CcSEcCtD
Remifentanil—Nausea—Trandolapril—coronary artery disease	8.34e-05	0.000339	CcSEcCtD
Remifentanil—Urticaria—Ramipril—coronary artery disease	8.32e-05	0.000338	CcSEcCtD
Remifentanil—Nausea—Enalapril—coronary artery disease	8.31e-05	0.000337	CcSEcCtD
Remifentanil—Vomiting—Perindopril—coronary artery disease	8.28e-05	0.000336	CcSEcCtD
Remifentanil—Body temperature increased—Ramipril—coronary artery disease	8.28e-05	0.000336	CcSEcCtD
Remifentanil—Rash—Perindopril—coronary artery disease	8.21e-05	0.000334	CcSEcCtD
Remifentanil—Dermatitis—Perindopril—coronary artery disease	8.2e-05	0.000333	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.2e-05	0.000333	CcSEcCtD
Remifentanil—Nausea—Telmisartan—coronary artery disease	8.19e-05	0.000333	CcSEcCtD
Remifentanil—Headache—Perindopril—coronary artery disease	8.16e-05	0.000331	CcSEcCtD
Remifentanil—Urticaria—Timolol—coronary artery disease	8.14e-05	0.00033	CcSEcCtD
Remifentanil—Pain—Lisinopril—coronary artery disease	8.12e-05	0.00033	CcSEcCtD
Remifentanil—Constipation—Lisinopril—coronary artery disease	8.12e-05	0.00033	CcSEcCtD
Remifentanil—Body temperature increased—Timolol—coronary artery disease	8.1e-05	0.000329	CcSEcCtD
Remifentanil—Dizziness—Losartan—coronary artery disease	8.08e-05	0.000328	CcSEcCtD
Remifentanil—Vomiting—Furosemide—coronary artery disease	8.05e-05	0.000327	CcSEcCtD
Remifentanil—Rash—Furosemide—coronary artery disease	7.98e-05	0.000324	CcSEcCtD
Remifentanil—Dermatitis—Furosemide—coronary artery disease	7.98e-05	0.000324	CcSEcCtD
Remifentanil—Nausea—Captopril—coronary artery disease	7.97e-05	0.000324	CcSEcCtD
Remifentanil—Headache—Furosemide—coronary artery disease	7.93e-05	0.000322	CcSEcCtD
Remifentanil—Feeling abnormal—Lisinopril—coronary artery disease	7.83e-05	0.000318	CcSEcCtD
Remifentanil—Vomiting—Losartan—coronary artery disease	7.77e-05	0.000316	CcSEcCtD
Remifentanil—Nausea—Perindopril—coronary artery disease	7.74e-05	0.000314	CcSEcCtD
Remifentanil—Hypersensitivity—Ramipril—coronary artery disease	7.72e-05	0.000314	CcSEcCtD
Remifentanil—Rash—Losartan—coronary artery disease	7.7e-05	0.000313	CcSEcCtD
Remifentanil—Dermatitis—Losartan—coronary artery disease	7.7e-05	0.000313	CcSEcCtD
Remifentanil—Headache—Losartan—coronary artery disease	7.65e-05	0.000311	CcSEcCtD
Remifentanil—Urticaria—Lisinopril—coronary artery disease	7.55e-05	0.000307	CcSEcCtD
Remifentanil—Hypersensitivity—Timolol—coronary artery disease	7.54e-05	0.000306	CcSEcCtD
Remifentanil—Nausea—Furosemide—coronary artery disease	7.52e-05	0.000306	CcSEcCtD
Remifentanil—Body temperature increased—Lisinopril—coronary artery disease	7.51e-05	0.000305	CcSEcCtD
Remifentanil—Pruritus—Ramipril—coronary artery disease	7.41e-05	0.000301	CcSEcCtD
Remifentanil—Nausea—Losartan—coronary artery disease	7.26e-05	0.000295	CcSEcCtD
Remifentanil—Pruritus—Timolol—coronary artery disease	7.25e-05	0.000294	CcSEcCtD
Remifentanil—Diarrhoea—Ramipril—coronary artery disease	7.17e-05	0.000291	CcSEcCtD
Remifentanil—Diarrhoea—Timolol—coronary artery disease	7.01e-05	0.000285	CcSEcCtD
Remifentanil—Hypersensitivity—Lisinopril—coronary artery disease	7e-05	0.000284	CcSEcCtD
Remifentanil—Dizziness—Ramipril—coronary artery disease	6.93e-05	0.000281	CcSEcCtD
Remifentanil—Dizziness—Timolol—coronary artery disease	6.77e-05	0.000275	CcSEcCtD
Remifentanil—Pruritus—Lisinopril—coronary artery disease	6.72e-05	0.000273	CcSEcCtD
Remifentanil—Vomiting—Ramipril—coronary artery disease	6.66e-05	0.000271	CcSEcCtD
Remifentanil—Rash—Ramipril—coronary artery disease	6.6e-05	0.000268	CcSEcCtD
Remifentanil—Dermatitis—Ramipril—coronary artery disease	6.6e-05	0.000268	CcSEcCtD
Remifentanil—Headache—Ramipril—coronary artery disease	6.56e-05	0.000267	CcSEcCtD
Remifentanil—Vomiting—Timolol—coronary artery disease	6.51e-05	0.000265	CcSEcCtD
Remifentanil—Diarrhoea—Lisinopril—coronary artery disease	6.5e-05	0.000264	CcSEcCtD
Remifentanil—Rash—Timolol—coronary artery disease	6.46e-05	0.000262	CcSEcCtD
Remifentanil—Dermatitis—Timolol—coronary artery disease	6.45e-05	0.000262	CcSEcCtD
Remifentanil—Headache—Timolol—coronary artery disease	6.42e-05	0.000261	CcSEcCtD
Remifentanil—Dizziness—Lisinopril—coronary artery disease	6.28e-05	0.000255	CcSEcCtD
Remifentanil—Nausea—Ramipril—coronary artery disease	6.22e-05	0.000253	CcSEcCtD
Remifentanil—Nausea—Timolol—coronary artery disease	6.08e-05	0.000247	CcSEcCtD
Remifentanil—Vomiting—Lisinopril—coronary artery disease	6.04e-05	0.000245	CcSEcCtD
Remifentanil—Rash—Lisinopril—coronary artery disease	5.99e-05	0.000243	CcSEcCtD
Remifentanil—Dermatitis—Lisinopril—coronary artery disease	5.98e-05	0.000243	CcSEcCtD
Remifentanil—Headache—Lisinopril—coronary artery disease	5.95e-05	0.000242	CcSEcCtD
Remifentanil—Nausea—Lisinopril—coronary artery disease	5.64e-05	0.000229	CcSEcCtD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—coronary artery disease	2.02e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL12—coronary artery disease	2.02e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BDKRB2—coronary artery disease	2.02e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PPP2CA—coronary artery disease	2.01e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—POMC—coronary artery disease	2.01e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—F2—coronary artery disease	2.01e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL2—coronary artery disease	2e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL3—coronary artery disease	2e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6ST—coronary artery disease	2e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2R—coronary artery disease	1.98e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SDC1—coronary artery disease	1.98e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUNB—coronary artery disease	1.98e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCD—coronary artery disease	1.98e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB2—coronary artery disease	1.97e-05	0.000179	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLCB1—coronary artery disease	1.97e-05	0.000179	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCE—coronary artery disease	1.95e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—JAK2—coronary artery disease	1.95e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS1—coronary artery disease	1.94e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGB—coronary artery disease	1.94e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—S100B—coronary artery disease	1.94e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—coronary artery disease	1.93e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—C3—coronary artery disease	1.93e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR7—coronary artery disease	1.93e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRB—coronary artery disease	1.92e-05	0.000175	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS3—coronary artery disease	1.92e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KITLG—coronary artery disease	1.9e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFBR2—coronary artery disease	1.9e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—THBS1—coronary artery disease	1.89e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PSMA6—coronary artery disease	1.87e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PSMB5—coronary artery disease	1.87e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—F2—coronary artery disease	1.87e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP3—coronary artery disease	1.85e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT5A—coronary artery disease	1.85e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ITGAV—coronary artery disease	1.84e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—coronary artery disease	1.84e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KNG1—coronary artery disease	1.83e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—POMC—coronary artery disease	1.83e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CREB1—coronary artery disease	1.83e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGTR1—coronary artery disease	1.82e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRA—coronary artery disease	1.81e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CYBA—coronary artery disease	1.8e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB1—coronary artery disease	1.8e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DUSP6—coronary artery disease	1.8e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOB—coronary artery disease	1.79e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—coronary artery disease	1.79e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6R—coronary artery disease	1.78e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL10—coronary artery disease	1.78e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLG—coronary artery disease	1.78e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—coronary artery disease	1.78e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—JAK2—coronary artery disease	1.77e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLAT—coronary artery disease	1.77e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDN1—coronary artery disease	1.76e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL5—coronary artery disease	1.75e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB2—coronary artery disease	1.73e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF1—coronary artery disease	1.72e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CSF2—coronary artery disease	1.72e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LPL—coronary artery disease	1.71e-05	0.000156	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCE—coronary artery disease	1.71e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—JAK2—coronary artery disease	1.71e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BDKRB2—coronary artery disease	1.7e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL12—coronary artery disease	1.7e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS1—coronary artery disease	1.7e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—POMC—coronary artery disease	1.7e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—S100B—coronary artery disease	1.7e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—F2—coronary artery disease	1.7e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MEF2C—coronary artery disease	1.69e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RPS6KB1—coronary artery disease	1.69e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6ST—coronary artery disease	1.69e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS3—coronary artery disease	1.68e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUNB—coronary artery disease	1.67e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLCB1—coronary artery disease	1.67e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFBR2—coronary artery disease	1.66e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KITLG—coronary artery disease	1.66e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ITGB3—coronary artery disease	1.65e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR7—coronary artery disease	1.63e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT5A—coronary artery disease	1.63e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP3—coronary artery disease	1.63e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—coronary artery disease	1.61e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PPP2CA—coronary artery disease	1.6e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCD—coronary artery disease	1.58e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOB—coronary artery disease	1.57e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—coronary artery disease	1.56e-05	0.000142	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ITGAV—coronary artery disease	1.55e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KNG1—coronary artery disease	1.55e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—JAK2—coronary artery disease	1.55e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDN1—coronary artery disease	1.55e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—POMC—coronary artery disease	1.54e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CREB1—coronary artery disease	1.54e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—coronary artery disease	1.54e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGTR1—coronary artery disease	1.54e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—C3—coronary artery disease	1.54e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL5—coronary artery disease	1.53e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—coronary artery disease	1.51e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CSF2—coronary artery disease	1.51e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF1—coronary artery disease	1.51e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6R—coronary artery disease	1.51e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL10—coronary artery disease	1.51e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLG—coronary artery disease	1.5e-05	0.000137	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LPL—coronary artery disease	1.5e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RPS6KB1—coronary artery disease	1.49e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MEF2C—coronary artery disease	1.49e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—coronary artery disease	1.47e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—coronary artery disease	1.46e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB2—coronary artery disease	1.46e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ITGB3—coronary artery disease	1.45e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCE—coronary artery disease	1.44e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—JAK2—coronary artery disease	1.44e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS1—coronary artery disease	1.44e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—S100B—coronary artery disease	1.44e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—coronary artery disease	1.43e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—coronary artery disease	1.43e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS3—coronary artery disease	1.42e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOA1—coronary artery disease	1.42e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—coronary artery disease	1.41e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PPP2CA—coronary artery disease	1.41e-05	0.000128	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFBR2—coronary artery disease	1.41e-05	0.000128	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KITLG—coronary artery disease	1.41e-05	0.000128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—coronary artery disease	1.4e-05	0.000128	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK14—coronary artery disease	1.4e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCD—coronary artery disease	1.38e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP3—coronary artery disease	1.37e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT5A—coronary artery disease	1.37e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—coronary artery disease	1.37e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—coronary artery disease	1.35e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—F2—coronary artery disease	1.35e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FN1—coronary artery disease	1.35e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—C3—coronary artery disease	1.35e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6ST—coronary artery disease	1.35e-05	0.000122	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKBIA—coronary artery disease	1.34e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOB—coronary artery disease	1.33e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—coronary artery disease	1.32e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—JAK2—coronary artery disease	1.31e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDN1—coronary artery disease	1.31e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL5—coronary artery disease	1.3e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KIT—coronary artery disease	1.29e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—coronary artery disease	1.29e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—coronary artery disease	1.28e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF1—coronary artery disease	1.28e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CSF2—coronary artery disease	1.28e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LPL—coronary artery disease	1.27e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—coronary artery disease	1.26e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—coronary artery disease	1.26e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MEF2C—coronary artery disease	1.26e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RPS6KB1—coronary artery disease	1.26e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA1—coronary artery disease	1.24e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GSK3B—coronary artery disease	1.24e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—POMC—coronary artery disease	1.23e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CREB1—coronary artery disease	1.23e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—coronary artery disease	1.23e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ITGB3—coronary artery disease	1.22e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK14—coronary artery disease	1.22e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—coronary artery disease	1.2e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6R—coronary artery disease	1.2e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—coronary artery disease	1.2e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	1.2e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	1.19e-05	0.000108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FN1—coronary artery disease	1.19e-05	0.000108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—F2—coronary artery disease	1.19e-05	0.000108	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—coronary artery disease	1.18e-05	0.000108	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	1.18e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	1.18e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	1.17e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	1.17e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	1.14e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—C3—coronary artery disease	1.14e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KIT—coronary artery disease	1.13e-05	0.000103	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.13e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	1.12e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF2—coronary artery disease	1.09e-05	9.9e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	1.09e-05	9.9e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	1.09e-05	9.9e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—coronary artery disease	1.08e-05	9.86e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—POMC—coronary artery disease	1.08e-05	9.82e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CREB1—coronary artery disease	1.08e-05	9.82e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—coronary artery disease	1.07e-05	9.77e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—coronary artery disease	1.06e-05	9.66e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—coronary artery disease	1.06e-05	9.66e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—coronary artery disease	1.06e-05	9.61e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6R—coronary artery disease	1.05e-05	9.58e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA1—coronary artery disease	1.05e-05	9.55e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAK2—coronary artery disease	1.04e-05	9.49e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—coronary artery disease	1.04e-05	9.47e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—coronary artery disease	1.04e-05	9.45e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	1.03e-05	9.4e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	1.03e-05	9.4e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	1.02e-05	9.3e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—coronary artery disease	1.01e-05	9.22e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2—coronary artery disease	1e-05	9.11e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FN1—coronary artery disease	1e-05	9.11e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	9.98e-06	9.07e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	9.9e-06	9e-05	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	9.88e-06	8.98e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	9.86e-06	8.97e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KIT—coronary artery disease	9.59e-06	8.72e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF2—coronary artery disease	9.55e-06	8.68e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	9.53e-06	8.66e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—coronary artery disease	9.42e-06	8.56e-05	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	9.2e-06	8.37e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	9.2e-06	8.37e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAK2—coronary artery disease	9.15e-06	8.32e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—POMC—coronary artery disease	9.13e-06	8.3e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CREB1—coronary artery disease	9.13e-06	8.3e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—coronary artery disease	9.12e-06	8.29e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—coronary artery disease	9.06e-06	8.24e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	8.97e-06	8.16e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—coronary artery disease	8.93e-06	8.12e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6R—coronary artery disease	8.9e-06	8.1e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—coronary artery disease	8.88e-06	8.07e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—coronary artery disease	8.78e-06	7.98e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	8.74e-06	7.95e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—coronary artery disease	8.62e-06	7.84e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	8.36e-06	7.6e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	8.35e-06	7.6e-05	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	8.35e-06	7.59e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	8.34e-06	7.58e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF2—coronary artery disease	8.07e-06	7.34e-05	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	8.07e-06	7.34e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—coronary artery disease	8e-06	7.27e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—coronary artery disease	7.96e-06	7.24e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—coronary artery disease	7.94e-06	7.22e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—coronary artery disease	7.78e-06	7.08e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	7.74e-06	7.04e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAK2—coronary artery disease	7.74e-06	7.03e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	7.58e-06	6.89e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—coronary artery disease	7.56e-06	6.87e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	7.33e-06	6.66e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	7.1e-06	6.46e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	7.06e-06	6.42e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	6.96e-06	6.33e-05	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	6.82e-06	6.2e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	6.78e-06	6.17e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—coronary artery disease	6.76e-06	6.15e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—coronary artery disease	6.71e-06	6.11e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—coronary artery disease	6.58e-06	5.98e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—coronary artery disease	6.39e-06	5.81e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	6.23e-06	5.66e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	6.19e-06	5.63e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	6.11e-06	5.55e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	6.04e-06	5.5e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	5.73e-06	5.21e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—coronary artery disease	5.35e-06	4.87e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	5.3e-06	4.82e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	5.26e-06	4.79e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	5.16e-06	4.69e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—coronary artery disease	4.94e-06	4.49e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—coronary artery disease	4.69e-06	4.27e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	4.48e-06	4.07e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—coronary artery disease	4.33e-06	3.94e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—coronary artery disease	3.97e-06	3.61e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—coronary artery disease	3.66e-06	3.33e-05	CbGpPWpGaD
